Selta Square Automates Pharmacovigilance with Oracle Argus

Selta Square, a valued collaborator expanding through the Business Process Services (BPS) model to reach new customers, is using Oracle Argus to deliver comprehensive drug safety solutions to the rapidly expanding South Korean life sciences market. With Oracle Argus, Selta Square can provide comprehensive and reliable safety case processing for its clients to support patient safety, regulatory compliance, and foster regional growth. Selta Square utilizes their own technologies, especially in data migration and safety data standardization, to enhance the capabilities and efficiency of the Oracle Argus platform.

With Oracle Argus safety platform Selta Square can automate case processing and global regulatory reporting workflows for its clients. This enables faster turnaround times, helps reduce manual effort, and helps Selta Square align with South Korea’s Ministry of Food and Drug Safety standards and international regulatory bodies, such as the European Medicines Agency and the US Food and Drug Administration, so clients can expand their reach into new regions.

“Working with Oracle is a strategically important step for Selta Square and for the advancement of life sciences and to drive more effective and efficient pharmacovigilance in South Korea,” said Min Kyung Shin, chief executive officer, Selta Square. “Argus delivers the innovative and robust pharmacovigilance capabilities our clients need to adapt to the dynamic regulatory landscape, accelerate their growth, and expand their businesses globally.”

“Our trusted, proven pharmacovigilance solutions are used by leading pharmaceutical companies to address safety standards around the globe and accelerate their drug safety processes,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “Oracle Argus leads the way to next-generation multivigilance through AI-driven automation and data science-based innovation.”

Oracle Argus is a leading, trusted solution for processing, analyzing, and reporting adverse event cases originating in premarket and post-market drugs, biologics, vaccines, devices, and combination products.

To learn more about Oracle’s pharmacovigilance portfolio visit: https://www.oracle.com/safety.

Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements—empowering the Life Sciences industry to improve patient outcomes. Learn more at www.oracle.com/lifesciences.

Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at oracle.com.

Oracle, Java, MySQL, and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.